The U.S. Federal Trade Commission sued the country’s three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies. The case accuses…[#item_full_content]
Sciopero dei treni, cancellazioni e possibili disagi. Gli elenchi dei convogli garantiti
Novembre 24, 2024
Read More [#item_full_content]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish